A clinical investigation and medical assessment were performed.During the investigation, the facility reported that the patient died during treatment from septic shock due to his gall bladder bursting because of a severe infection.The facility reported that their biomed technician tested the machine and found no malfunctions with the device.Per the fms associate medical director, there is no current information to suggest that the patient's death was product related and there is no report of product malfunction.The investigation was limited by the fact that the patient's medical records and treatment information were not available for review.The actual device was not returned to the manufacturer.A fms hemodialysis technician serviced the machine at the user facility site.A visual inspection identified that the machine was functioning correctly.There was no additional evaluation available.This is a retrospective mdr being submitted by fresenius medical care as a remediation action committed to fda regarding all potential adverse events received between march 21, 2011 to march 11, 2013.
|